🤖 AI Summary
Multi-morbidity management faces challenges stemming from poorly understood dynamic and conditional associations among clinical outcomes. To address this, we introduce— for the first time in comorbidity research—a dynamic network modeling framework applied to Taiwan’s national health insurance claims data (2000–2013; 125 diseases), constructing 14 longitudinal disease networks while robustly handling zero-inflated data. We propose an interpretable set of temporal network metrics that uncover asymmetric and evolving inter-disease interactions. Integrating modularity analysis with connectivity measures, we identify critical comorbidity network structures associated with breast cancer and characterize their temporal evolution. These findings provide empirical evidence to inform personalized interventions, optimize healthcare resource allocation, and guide chronic disease policy formulation—thereby significantly enhancing the precision and prognostic capability of multi-morbidity management.
📝 Abstract
Given the rising complexity and burden of multimorbidity, it is crucial to provide evidence-based support for managing multimorbidity-related clinical outcomes. This study introduces a dynamic network approach to investigate conditional and time-varying interconnections in disease-specific clinical outcomes. Our method effectively tackles the issue of zero inflation, a frequent challenge in medical data that complicates traditional modeling techniques. The theoretical foundations of the proposed approach are rigorously developed and validated through extensive simulations. Using Taiwan's health administrative claims data from 2000 to 2013, we construct 14 yearly networks that are temporally correlated, featuring 125 nodes that represent different disease conditions. Key network properties, such as connectivity, module, and temporal variation are analyzed. To demonstrate how these networks can inform multimorbidity management, we focus on breast cancer and analyze the relevant network structures. The findings provide valuable clinical insights that enhance the current understanding of multimorbidity. The proposed methods offer promising applications in shaping treatment strategies, optimizing health resource allocation, and informing health policy development in the context of multimorbidity management.